Italia markets closed

BMY Sep 2024 43.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,7200-0,0200 (-1,15%)
In data: 10:12AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,7400
Aperto1,7100
Denaro1,6100
Lettera1,6500
Prezzo d'esercizio43,00
Scadenza2024-09-20
Min-Max giorno1,7100 - 1,7200
Contratto - Min-MaxN/D
Volume2
Open Interest3,16k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri